We are live on ! Find out more
AMAM

Ambrx Biopharma Inc

Delisted

AMAM was delisted on the 6th of March, 2024.

Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$3.88M -$554K -269,212 -7%
BlackRock
2
BlackRock
New York
$3.08M -$109 -53 -0%
CAM
3
Cormorant Asset Management
Massachusetts
$2.52M -$309K -149,997 -6%
AG
4
Artal Group
Luxembourg
$2.32M
Adage Capital Partners
5
Adage Capital Partners
Massachusetts
$2.19M
FI
6
Fosun International
China
$2.09M
SCM
7
Suvretta Capital Management
New York
$1.61M
Millennium Management
8
Millennium Management
New York
$123K +$22.5K +10,916 +11%
Renaissance Technologies
9
Renaissance Technologies
New York
$69K +$109K +53,000 +482%
Royal Bank of Canada
10
Royal Bank of Canada
Ontario, Canada
$46K +$87.4K +42,453 New
Susquehanna International Group
11
Susquehanna International Group
Pennsylvania
$21K +$39.6K +19,220 New
Tudor Investment Corp
12
Tudor Investment Corp
Connecticut
$18K -$5.66K -2,748 -14%
Citadel Advisors
13
Citadel Advisors
Florida
$13K +$25K +12,116 New
UBS Group
14
UBS Group
Switzerland
$9K +$15.9K +7,725 +3,192%
OCA
15
Octagon Capital Advisors
New York
-$325K -122,800 Closed
Norges Bank
16
Norges Bank
Norway
-$165K -62,396 Closed
TRCT
17
Tower Research Capital (TRC)
New York
+$86 +42 New